| Company Name | Date | Purpose |
|
Avantel
|
11-Jul-26
| Avantel Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 inter alia to consider and approve Board Meeting Intimation for Approval of Q1 Results - FY 2026-27 |
|
Avenue Super.
|
11-Jul-26
| Quarterly Results & Inter alia, to consider and approve raising of funds by issue of Debt securities by way of private placement |
|
Bijoy Hans
|
11-Jul-26
| Bijoy Hans Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 inter alia to consider and approve
1. To consider & approve Acquisition of Sushodha Institute of Gastroenterology Private Limited and approval of Material Related Party Transactions with Mr. Bidari Kotresh Anilkumar.
2. To consider and evaluate a proposal for issuance of equity shares on a preferential basis for consideration other than cash (share swap).
3. To constitute Right Issue Committee of a Company.
4. To consider proposal to issue securities to the existing shareholders of the Company on Rights Basis as may be permitted under applicable law subject to such regulatory/statutory approvals as may be required.
5. To consider the approval for the postal ballot process and related actions. |
|
Digicontent
|
11-Jul-26
| Inter alia, to consider and approve:- (1) the proposal for issue of securities including equity shares, convertible securities, bonds, debentures by way of a preferential issue, rights issue or any other method or combinations thereof, subject to such regulatory / statutory approvals as may be required, including the approval of theshareholders of the Company. |
|
Goodluck India
|
11-Jul-26
| Goodluck India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/07/2026 ,inter alia, to consider and approve a) Issue of Bonus Equity Shares of the Company, subject to such statutory, regulatory and shareholders'' approvals as may be required. b) In principle, the proposed Corporate Restructuring of the Company, including evaluation of various restructuring options, subject to applicable laws and such approvals as may be required. |
|